Descovy
Generic: emtricitabine/tenofovir alafenamide
Manufacturer: Gilead Sciences · Program: Gilead Advancing Access Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or underinsured patients; not eligible if enrolled in government programs like Medicare, Medicaid, TRICARE, VA
Residency
US resident
Income Threshold
Up to 500% FPL
Individual Income Limit
$72,900/year
IMPORTANT: Medicare Part D patients are NOT eligible for most Gilead PAP programs
Program Information
Processing Time
1–2 weeks
Delivery Method
shipped to patient or physician office
Application Method
Multiple
Reauthorization
Required, annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- proof of income
- proof of residency
- prescription
- proof of insurance status
Indicated For
HIV-1 treatment, HIV-1 PrEP
About This Medication
# Gilead Advancing Access Patient Assistance Program Patient Guide: How to Get Descovy (emtricitabine/tenofovir alafenamide) at Low or No Cost Descovy is a prescription medication from Gilead Sciences used to treat HIV infection in certain adults and children, and as **pre-exposure prophylaxis (PrEP)** to reduce the risk of sexually acquired HIV in adults and adolescents at high risk. This guide explains the **Gilead Advancing Access Patient Assistance Program (PAP/MAP)**, which provides **Descovy free of charge** to eligible uninsured or underinsured patients meeting income criteria.[1][3][4] ## Who Qualifies for the Program? The program helps patients who cannot afford their medication due to financial hardship. Key eligibility factors include: - **Uninsured or underinsured** status. - **Household income at or below 500% of the Federal Poverty Level (FPL)**. - **U.S. residency**. - **Not enrolled in government programs** like Medicare, Medicaid, TRICARE, or VA benefits.[1][3][4] **Important:** Even if you have commercial insurance, separate co-pay assistance may reduce costs to $0, but PAP/MAP is primarily for those without adequate coverage.[3][4][6] ## About Descovy **Descovy** combines **emtricitabine** and **tenofovir alafenamide**, two antiretroviral drugs that work together to block HIV from multiplying in the body. For **HIV treatment**, it's used with other antiretrovirals in adults and children (weighing at least 25 kg) who are treatment-naïve or switching regimens, with no known resistance. For **PrEP**, it prevents HIV infection in at-risk individuals when taken daily, but it does **not prevent other STIs** and requires HIV testing before starting and periodically.[3] Common side effects include nausea, diarrhea, headache, and fatigue. Serious risks involve kidney problems, bone density loss, or lactic acidosis—discuss with your doctor. Descovy is a tablet taken once daily with or without food.[1][3] Always follow your healthcare provider's instructions. This program does not replace medical advice. ## Income Eligibility Breakdown Eligibility is based on **total household income** compared to the **Federal Poverty Level (FPL)**, which adjusts yearly for household size. The threshold is **500% of FPL**—generous compared to many programs.[1] Here's a table with **2026 FPL estimates** (based on 2025 guidelines; check HHS.gov for exact figures): | Household Size | Annual Income Limit (500% FPL) | |----------------|--------------------------------| | 1 (Individual) | $73,600 | | 2 (Couple) | $100,000 | | 3 | $126,400 | | 4 | $152,800 | | +1 Member | Add ~$26,400 each | **Notes:** Income includes wages, Social Security, etc. Deductions may apply (e.g., high medical costs). Provide recent tax returns, pay stubs, or benefit statements as proof.[1] ## Insurance Requirements - **Eligible:** Uninsured patients or underinsured (high co-pays/deductibles) with commercial insurance may qualify for PAP/MAP if income criteria are met. - **Not Eligible:** Enrolled in **Medicare Part D, Medicaid, TRICARE, VA, or AIDS Drug Assistance Program (ADAP)**. Government program participants should explore those benefits first.[1][3][4][5] If your insurance changes, contact the program—they can help navigate appeals or alternatives.[1][8] ## Step-by-Step Application Process 1. **Get a Prescription:** Ask your doctor for Descovy and confirm it's for treatment or PrEP.[9] 2. **Contact or Enroll:** Call **(800) 226-2056** (Mon-Fri, 9 AM-8 PM ET) or download the enrollment form from GileadAdvancingAccess.com. A specialist guides you.[1][9] 3. **Gather Documents:** - **Proof of income** (tax return, W-2, pay stubs). - **Proof of residency** (utility bill, lease). - **Prescription** from your doctor. - **Proof of insurance status** (denial letter or insurance card showing lack of coverage).[1] 4. **Submit Application:** Fax to (800) 216-6857, mail, or submit online/via phone. Doctor or patient can initiate.[9] 5. **Wait for Approval:** Processing takes **2-4 weeks**. You'll get a call or letter.[1] **Tip:** Specify if for PrEP on the form.[9] ## Timeline and Delivery - **Processing:** 2-4 weeks after complete submission. - **Delivery:** Medication shipped **free to your home or doctor's office** for up to 12 months supply, depending on approval.[1][4] - **Reauthorization:** **Required annually** or upon changes. Re-enroll if insurance lapses, but not if on Medicaid/ADAP.[1] Track status by calling the helpline. ## Alternatives if Denied - **Appeal:** Provide more info or updated documents. - **Co-pay Program:** For commercial insurance—up to $7,200/year, often $0 co-pay (98% of users).[3][4][6] - **State Programs:** ADAP, Ryan White HIV/AIDS Program. - **Generic Options:** No biosimilars listed; discuss alternatives like Truvada with your doctor. - **Manufacturer Help:** Call for benefits investigation or prior auth support.[1][8] ## Disclaimer This guide is for informational purposes only and based on program details as of 2026. Eligibility, terms, and FPL change—verify with Gilead at (800) 226-2056 or GileadAdvancingAccess.com. Not medical/financial advice. Consult your doctor for treatment suitability. Program availability subject to change; Gilead may discontinue or modify.[1][3] *(Word count: 1028)*
Program information last verified: March 30, 2026
Ready to apply for Descovy assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.